Moderna, Inc.

Historical 13F Holders

Symbol
MRNA
CUSIP
60770K107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 60770K107 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
13.1% 8/6/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 6.5% 4/30/2026
Event 3/31/2026
Capital World Investors 13G 5.6% 8/12/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Baillie Gifford & Co 13G/A 4.6% 7/24/2026
Event 6/30/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 33 1.31 M $254 M
2026 Q2 874 346 M $22.7 B
2026 Q1 808 308 M $15.6 B
2025 Q4 764 305 M $9.02 B
2025 Q3 737 277 M $7.17 B
2025 Q2 761 303 M $8.35 B
2025 Q1 779 282 M $8.00 B
2024 Q4 849 277 M $11.5 B
2024 Q3 894 265 M $17.7 B
2024 Q2 1,069 269 M $32.0 B
2024 Q1 1,010 276 M $29.4 B
2023 Q4 991 269 M $26.8 B
2023 Q3 990 247 M $25.9 B
2023 Q2 1,057 249 M $30.3 B
2023 Q1 1,115 273 M $38.6 B
2022 Q4 1,178 263 M $47.6 B
2022 Q3 1,011 248 M $29.4 B
2022 Q2 1,133 245 M $35.0 B
2022 Q1 1,122 251 M $43.3 B
2021 Q4 1,213 250 M $63.5 B
2021 Q3 1,247 243 M $93.6 B
2021 Q2 999 229 M $53.9 B
2021 Q1 860 210 M $27.5 B
2020 Q4 808 201 M $21.1 B
2020 Q3 628 206 M $14.5 B
2020 Q2 544 220 M $14.1 B
2020 Q1 336 196 M $5.88 B
2019 Q4 177 177 M $3.45 B
2019 Q3 151 169 M $2.69 B
2019 Q2 161 144 M $2.10 B
2019 Q1 115 138 M $2.80 B
2018 Q4 83 134 M $2.02 B